Aptivus
Drug timelines are a Plus or Pro feature.
30 regulatory and trial events tracked for Aptivus, covering 2006-08-11 to 2026-04-23. Get the full timeline:
Most recent: EMA Authorised: Aptivus (tipranavir) — Boehringer Ingelheim International GmbH